Vimarsana
Biggest News Aggregation in the World

Page 39 - Beigene News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beigene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beigene Today - Breaking & Trending Today

BeiGene (NASDAQ:BGNE) Shares Gap Down to $184.00 - Vimarsana News

BeiGene (NASDAQ:BGNE) Shares Gap Down to $184.00

BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) gapped down before the market opened on Friday . The stock had previously closed at $184.00, but opened at $177.01. BeiGene shares last traded at $177.20, with a volume of 1,257 shares. BGNE has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft initiated coverage […]

BeiGene, Ltd.: China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors - Vimarsana News

BeiGene, Ltd.: China NMPA Approves Tislelizumab for Patients with Microsatellite Instability-High or Mismatch Repair-Deficient Solid Tumors

Tislelizumab is now approved in seven indications in China BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative

BeiGene, Hutchmed, Zai Lab tagged for potential US delisting under SEC audit rules, with more Chinese biotechs likely to face scrutiny - Vimarsana News

BeiGene, Hutchmed, Zai Lab tagged for potential US delisting under SEC audit rules, with more Chinese biotechs likely to face scrutiny

The U.S.

Fierce Pharma Asia—Legend CEO's cell therapy ambitions; Indian pharmas' awkward position; new Hutchmed CEO - Vimarsana News

Fierce Pharma Asia—Legend CEO's cell therapy ambitions; Indian pharmas' awkward position; new Hutchmed CEO

After its first commercial launch in Carvykti, Legend Biotech's CEO talked up the rising CAR-T star's cell therapy ambitions.

Chinese Stocks Are Down Sharply on Thursday. Here's What Could Be Behind the Decline - Vimarsana News

Chinese Stocks Are Down Sharply on Thursday. Here's What Could Be Behind the Decline

A 2020 law called the Holding Foreign Companies Accountable Act may be behind the sharp decline in a handful of U.S-traded Chinese stocks.